Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
John F. Seymour(The Royal Melbourne Hospital), Hervé Dombret(University of London Institute in Paris), Anna Candoni(University of Udine), Aleksandra Butrym(Wroclaw Medical University), Christian Récher(Institut universitaire du cancer de Toulouse Oncopole), C.L. Beach(Université Paris Cité), Agnieszka Wierzbowska(Medical University of Lodz), José Falantes(Hospital Universitario Virgen del Rocío), Mark D. Minden(University Health Network), Dominik Selleslag(National Institutes of Health), Rajat Kumar(University Health Network), James D. Cavenagh(National Health Service), Jun Ho Jang(Samsung Medical Center), Irwindeep Sandhu(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), S. Songer, Haifa Kathrin Al‐Ali(University Hospital in Halle), Richard M. Stone(Dana-Farber Cancer Institute), Hartmut Döhner(University Hospital Ulm), Jerry Weaver, Andre C. Schuh(University of Toronto)
Cited by 73
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k